For localized information and support, would you like to switch to your country-specific website for {0}?
Roche's commitment to advanced diagnostic solutions
Early and accurate diagnosis is crucial in the management and treatment of various health conditions. Our innovative diagnostic solutions address a wide range of health topics, with a special focus on cardiometabolic diseases, infectious diseases, neurology, oncology, and women's health.
By integrating cutting-edge technology with clinical expertise, we strive to provide healthcare professionals with the tools they need to make informed decisions, helping to ensure better health outcomes for patients worldwide.
Our extensive portfolio includes advanced testing methods and diagnostic tools that deliver precise and reliable results across diverse healthcare settings. Roche’s commitment to quality and innovation ensures that we remain at the forefront of diagnostic science, continuously improving and expanding our offerings to meet the evolving needs of healthcare providers and patients alike.
Enhancing patient care for a diverse range of health topics
Roche Diagnostics offers a wide range of diagnostic tools designed to address a wide range of health topics and challenges. Our advanced technology enables accurate detection, monitoring, and management of diseases, ensuring that healthcare professionals can provide timely and effective interventions. From routine screenings to complex diagnostic needs, our solutions are tailored to enhance patient care across various medical fields.
Your partner in enhancing healthcare
Our dedication goes beyond providing diagnostic tools. We collaborate closely with healthcare providers, offering support and expertise to optimize laboratory operations and improve clinical outcomes. With over a century of experience, Roche is a trusted partner in the global fight against disease, continually pushing the boundaries of what’s possible in medical diagnostics and innovating solutions that touch every stage of the patient journey.
Explore health topics
A comprehensive portfolio of innovative infectious diseases solutions - committed to working towards eliminating infectious diseases and helping to improve patient care.
Pioneering life-changing innovations that enable early detection of neurological disorders and help preserve in patients what makes them who they are.
Innovative solutions to help navigate life-changing oncology decisions and elevate cancer care outcomes.
IVD
For in vitro diagnostic use.
cobas® PIK3CA Mutation Test
The cobas® PIK3CA Mutation Test (cobas PIK3CA Test) is a research use only (RUO) real-time PCR test for the qualitative detection and identification of mutations in exons 1, 4, 7, 9, and 20 of the phosphoinositide-3-kinase, catalytic, alpha (PIK3CA) gene in DNA derived from formalin-fixed paraffin-embedded tissue (FFPET).
The cobas PIK3CA Test is based on two major processes: (1) manual sample preparation to obtain genomic DNA from FFPET; and (2) PCR amplification and detection of target DNA using complementary primer pairs and oligonucleotide probes labeled with fluorescent dyes. The test is designed to detect R88Q in exon 1, N345K in exon 4, C420R in exon 7, E542K, E545X (E545A, E545D*, E545G, and E545K), Q546X (Q546E, Q546K, Q546L, and Q546R) in exon 9, and M1043I † , H1047X (H1047L, H1047R, and H1047Y), and G1049R in exon 20 when the percent mutation is 5% or greater. Mutation detection is achieved through PCR analysis with the cobas z 480 analyzer. A mutant control and a negative control are included in each run to confirm the validity of the run.
IVD
For in vitro diagnostic use.
navify® Algorithms, GAAD
GAAD is an in vitro diagnostic multivariate index assay intended to provide a semi-quantitative result by combining in an algorithm the quantitative measurements of Elecsys AFP assay and Elecsys PIVKA‑II assay in human serum and plasma with gender and age.GAAD is intended as an aid in diagnosis of Hepatocellular Carcinoma (HCC) (early and all stages). GAAD is indicated for adults who meet the following criteria: diagnosis of chronic liver disease and recommended for surveillance due to increased risk of developing HCC. GAAD must be interpreted in conjunction with other diagnostic findings and clinical information in accordance with standard clinical management guidelines.
Optimizing cardiometabolic disease management together.
IVD
For in vitro diagnostic use.
cobas® h 232 POC system
Enabling confident on-the-spot diagnosis and management of patients presenting with signs and symptoms of cardiovascular disease
Innovative women’s health diagnostics addressing various medical needs to improve health outcomes for women across their lifespan.
